GENSIGHT BIOLOGICS (CIK 0001641634)
Source:SEC EDGAR database•Date:June 18, 2015•SIC:2836•CIK:2836
AMENDMENT NO. 1 TO THE CELL LINE LICENSE AGREEMENT
Source:SEC EDGAR database•Date:March 23, 2023•SIC:2836•CIK:2836
DYADIC INTERNATIONAL INC (DYAI) (CIK 0001213809)
Source:SEC EDGAR database•Date:November 13, 2019•SIC:2836•CIK:2836
SAMSUNG BIOLOGICS CO., LTD. AMENDMENT NO 1 TO PRODUCT SPECIFIC AGREEMENT CLINICAL PRODUCT DRUG SUBSTANCE
Source:SEC EDGAR database•Date:February 27, 2023•SIC:2834•CIK:2834
AMENDMENT NO. 4 TOLICENSE AGREEMENT
Source:SEC EDGAR database•Date:February 28, 2023•SIC:2834•CIK:2834
CONFIDENTIAL TREATMENT REQUESTED LICENSE AGREEMENT
Source:SEC EDGAR database•Date:February 5, 2018•SIC:2834•CIK:2834
AMENDMENT 1 TO THE MANUFACTURING AND TECHNOLOGY DEVELOPMENT MASTER AGREEMENT
Source:SEC EDGAR database•Date:March 14, 2023•SIC:2836•CIK:2836
LICENSE AND SUPPLY AGREEMENT
Source:SEC EDGAR database•Date:May 10, 2023•SIC:2834•CIK:2834
Consulting Agreement
Source:SEC EDGAR database•Date:May 2, 2023•SIC:2834•CIK:2834
CONFIDENTIAL TREATMENT REQUESTED LICENSE AGREEMENT
Source:SEC EDGAR database•Date:January 19, 2018•SIC:2834•CIK:2834